Takaisin Tulosta

Kohdunkaulan, emättimen ja ulkosynnytinten solumuutokset, näytönastekatsausten kirjallisuusviitteet

Lisätietoa aiheesta
29.3.2021

Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Kohdunkaulan, emättimen ja ulkosynnytinten solumuutokset «Kohdunkaulan, emättimen ja ulkosynnytinten solumuutokset»1 näytönastekatsauksissa arvioitu kirjallisuus.

Kirjallisuutta

  1. Aho M, Vesterinen E, Meyer B ym. Natural history of vaginal intraepithelial neoplasia. Cancer 1991;68:195-7 «PMID: 2049744»PubMed
  2. Andrae B, Kemetli L, Sparén P ym. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008;100:622-9 «PMID: 18445828»PubMed
  3. Andrae B, Strander B, Silfverdal L ym. Benefit of cervical cancer screening in young women – a matter of adherence to the recommended screening interval [Rapid Response]. BMJ 2009. http://www.bmj.com
  4. Anttila A, Kotaniemi-Talonen L, Leinonen M ym. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme. BMJ 2010;340:c1804 «PMID: 20423964»PubMed
  5. Arbyn M, Buntinx F, Van Ranst M ym. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004;96:280-93 «PMID: 14970277»PubMed
  6. Arbyn M, Kyrgiou M, Simoens C ym. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 2008;337:a1284 «PMID: 18801868»PubMed
  7. Arbyn M, Raifu AO, Weiderpass E ym. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 2009;45:2640-8 «PMID: 19695864»PubMed
  8. Arbyn M, Roelens J, Simoens C ym. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Cochrane Database Syst Rev 2013;:CD008054 «PMID: 23543559»PubMed
  9. Arbyn M, Ronco G, Anttila A ym. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 2012;30 Suppl 5:F88-99 «PMID: 23199969»PubMed
  10. ASCUS-LSIL Traige Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-92 «PMID: 12824967»PubMed
  11. Baalbergen A, Helmerhorst TJ. Adenocarcinoma in situ of the uterine cervix--a systematic review. Int J Gynecol Cancer 2014;24:1543-8 «PMID: 25238167»PubMed
  12. Blitz S, Baxter J, Raboud J ym. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women. J Infect Dis 2013;208:454-62 «PMID: 23624362»PubMed
  13. Bosgraaf RP, Verhoef VM, Massuger LF ym. Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening. Int J Cancer 2015;136:646-55 «PMID: 24923998»PubMed
  14. Bruinsma FJ, Quinn MA. The risk of preterm birth following treatment for precancerous changes in the cervix: a systematic review and meta-analysis. BJOG 2011;118:1031-41 «PMID: 21449928»PubMed
  15. Bulkmans NW, Berkhof J, Rozendaal L ym. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007;370:1764-72 «PMID: 17919718»PubMed
  16. Castanon A, Brocklehurst P, Evans H ym. Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study. BMJ 2012;345:e5174 «PMID: 22899563»PubMed
  17. Castañon A, Landy R, Brocklehurst P ym. Is the increased risk of preterm birth following excision for cervical intraepithelial neoplasia restricted to the first birth post treatment? BJOG 2015;122:1191-9 «PMID: 25854594»PubMed
  18. Castle PE, Schiffman M, Wheeler CM ym. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 2009;113:18-25 «PMID: 19104355»PubMed
  19. Conner SN, Frey HA, Cahill AG ym. Loop electrosurgical excision procedure and risk of preterm birth: a systematic review and meta-analysis. Obstet Gynecol 2014;123:752-61 «PMID: 24785601»PubMed
  20. Council of the European Union. Council recommendation of 2 December 2003 on cancer screening. Off J Eur Union 2003;878:34-8
  21. Crocetti E, Battisti L, Betta A ym. The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy. Eur J Cancer Prev 2007;16:564-7 «PMID: 18090131»PubMed
  22. Cruickshank ME, Cotton SC, Sharp L ym. Management of women with low grade cytology: how reassuring is a normal colposcopy examination? BJOG 2015;122:380-6 «PMID: 24947656»PubMed
  23. Cullimore J, Scurr J. The abnormal glandular smear: cytologic prediction, colposcopic correlation and clinical management. J Obstet Gynaecol 2000;20:403-7 «PMID: 15512597»PubMed
  24. De Vuyst H, Lillo F, Broutet N ym. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev 2008;17:545-54 «PMID: 18941376»PubMed
  25. Denslow SA, Rositch AF, Firnhaber C ym. Incidence and progression of cervical lesions in women with HIV: a systematic global review. Int J STD AIDS 2014;25:163-77 «PMID: 24216030»PubMed
  26. Discacciati MG, de Souza CA, d'Otavianno MG ym. Outcome of expectant management of cervical intraepithelial neoplasia grade 2 in women followed for 12 months. Eur J Obstet Gynecol Reprod Biol 2011;155:204-8 «PMID: 21193261»PubMed
  27. Elit L, Levine MN, Julian JA ym. Expectant management versus immediate treatment for low-grade cervical intraepithelial neoplasia : a randomized trial in Canada and Brazil. Cancer 2011;117:1438-45 «PMID: 21425144»PubMed
  28. Ellerbrock TV, Chiasson MA, Bush TJ ym. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000;283:1031-7 «PMID: 10697063»PubMed
  29. Etherington IJ, Luesley DM, Shafi MI ym. Observer variability among colposcopists from the West Midlands region. Br J Obstet Gynaecol 1997;104:1380-4 «PMID: 9422016»PubMed
  30. Eva LJ, Ganesan R, Chan KK ym. Differentiated-type vulval intraepithelial neoplasia has a high-risk association with vulval squamous cell carcinoma. Int J Gynecol Cancer 2009;19:741-4 «PMID: 19509581»PubMed
  31. Fidler HK, Boyes DA, Worth AJ. Cervical cancer detection in British Columbia. A progress report. J Obstet Gynaecol Br Commonw 1968;75:392-404 «PMID: 5647704»PubMed
  32. Flannelly G, Bolger B, Fawzi H ym. Follow up after LLETZ: could schedules be modified according to risk of recurrence? BJOG 2001;108:1025-30 «PMID: 11702832»PubMed
  33. Frega A, Sesti F, Sopracordevole F ym. Imiquimod 5% cream versus cold knife excision for treatment of VIN 2/3: a five-year follow-up. Eur Rev Med Pharmacol Sci 2013;17:936-40 «PMID: 23640441»PubMed
  34. Gage JC, Duggan MA, Nation JG ym. Detection of cervical cancer and its precursors by endocervical curettage in 13,115 colposcopically guided biopsy examinations. Am J Obstet Gynecol 2010;203:481.e1-9 «PMID: 20800216»PubMed
  35. Gamzu R, Almog B, Levin I ym. Clinical and economic implications of adding HPV tests to the routine cytology follow-up and management of patients with histologically defined cervical intraepithelial neoplasia grade 1. Gynecol Oncol 2002;86:129-33 «PMID: 12144817»PubMed
  36. Ghaem-Maghami S, De-Silva D, Tipples M ym. Determinants of success in treating cervical intraepithelial neoplasia. BJOG 2011;118:679-84 «PMID: 21083861»PubMed
  37. Ghaem-Maghami S, Sagi S, Majeed G ym. Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis. Lancet Oncol 2007;8:985-93 «PMID: 17928267»PubMed
  38. Gunderson CC, Nugent EK, Elfrink SH ym. A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia. Am J Obstet Gynecol 2013;208:410.e1-6 «PMID: 23380265»PubMed
  39. Gurumurthy M, Cotton SC, Sharp L ym. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. J Low Genit Tract Dis 2014;18:203-9 «PMID: 24270198»PubMed
  40. Gurumurthy M, Cruickshank ME. Management of vaginal intraepithelial neoplasia. J Low Genit Tract Dis 2012;16:306-12 «PMID: 22460272»PubMed
  41. Hellberg D, Nilsson S, Valentin J. Positive cervical smear with subsequent normal colposcopy and histology--frequency of CIN in a long-term follow-up. Gynecol Oncol 1994;53:148-51 «PMID: 8188072»PubMed
  42. Henes M, Neis F, Rall K ym. Abnormal cytology during pregnancy--a retrospective analysis of patients in a dysplasia clinic. Anticancer Res 2013;33:711-5 «PMID: 23393372»PubMed
  43. Herod JJ, Shafi MI, Rollason TP ym. Vulvar intraepithelial neoplasia: long term follow up of treated and untreated women. Br J Obstet Gynaecol 1996;103:446-52 «PMID: 8624318»PubMed
  44. Hillemanns P, Wang X, Staehle S ym. Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy. Gynecol Oncol 2006;100:271-5 «PMID: 16169064»PubMed
  45. Ho GY, Bierman R, Beardsley L ym. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8 «PMID: 9459645»PubMed
  46. Ho GY, Einstein MH, Romney SL ym. Risk factors for persistent cervical intraepithelial neoplasia grades 1 and 2: managed by watchful waiting. J Low Genit Tract Dis 2011;15:268-75 «PMID: 21811178»PubMed
  47. Hoffman M, Cooper D, Carrara H ym. Limited Pap screening associated with reduced risk of cervical cancer in South Africa. Int J Epidemiol 2003;32:573-7 «PMID: 12913031»PubMed
  48. Hopman EH, Kenemans P, Helmerhorst TJ. Positive predictive rate of colposcopic examination of the cervix uteri: an overview of literature. Obstet Gynecol Surv 1998;53:97-106 «PMID: 9487534»PubMed
  49. Hristova L, Hakama M. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017. Acta Oncol 1997;36 Suppl 9:1-60 «PMID: 9143316»PubMed
  50. Jadoon BA, Kehoe S, Romain K ym. Analysis of outcome in women with borderline glandular change on cervical cytology. Eur J Obstet Gynecol Reprod Biol 2009;147:83-5 «PMID: 19740591»PubMed
  51. Jakobsson M, Gissler M, Paavonen J ym. Loop electrosurgical excision procedure and the risk for preterm birth. Obstet Gynecol 2009;114:504-10 «PMID: 19701027»PubMed
  52. Jakobsson M, Gissler M, Sainio S ym. Preterm delivery after surgical treatment for cervical intraepithelial neoplasia. Obstet Gynecol 2007;109:309-13 «PMID: 17267829»PubMed
  53. Jones RW, Rowan DM, Stewart AW. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstet Gynecol 2005;106:1319-26 «PMID: 16319258»PubMed
  54. Joura EA, Giuliano AR, Iversen OE ym. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015;372:711-23 «PMID: 25693011»PubMed
  55. Kalliala I, Anttila A, Dyba T ym. Pregnancy incidence and outcome among patients with cervical intraepithelial neoplasia: a retrospective cohort study. BJOG 2012;119:227-35 «PMID: 21790950»PubMed
  56. Kalliala I, Anttila A, Nieminen P ym. Pregnancy incidence and outcome before and after cervical intraepithelial neoplasia: a retrospective cohort study. Cancer Med 2014;3:1512-6 «PMID: 25146172»PubMed
  57. Kamineni A, Weinmann S, Shy KK ym. Efficacy of screening in preventing cervical cancer among older women. Cancer Causes Control 2013;24:1653-60 «PMID: 23744043»PubMed
  58. Kapeu AS, Luostarinen T, Jellum E ym. Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. Am J Epidemiol 2009;169:480-8 «PMID: 19074773»PubMed
  59. Katki HA, Schiffman M, Castle PE ym. Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. J Low Genit Tract Dis 2013;17:S78-84 «PMID: 23519309»PubMed
  60. Keller MJ, Burk RD, Massad LS ym. Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test. Clin Infect Dis 2015;61:1573-81 «PMID: 26187020»PubMed
  61. Keller MJ, Burk RD, Xie X ym. Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection. JAMA 2012;308:362-9 «PMID: 22820789»PubMed
  62. Kelly RS, Walker P, Kitchener H ym. Incidence of cervical intraepithelial neoplasia grade 2 or worse in colposcopy-negative/human papillomavirus-positive women with low-grade cytological abnormalities. BJOG 2012;119:20-5 «PMID: 21624034»PubMed
  63. Khalid S, Dimitriou E, Conroy R ym. The thickness and volume of LLETZ specimens can predict the relative risk of pregnancy-related morbidity. BJOG 2012;119:685-91 «PMID: 22329499»PubMed
  64. Kierkegaard O, Byrjalsen C, Frandsen KH ym. Diagnostic accuracy of cytology and colposcopy in cervical squamous intraepithelial lesions. Acta Obstet Gynecol Scand 1994;73:648-51 «PMID: 7941991»PubMed
  65. Kietpeerakool C, Buttura R, Srisomboon J. An audit of standards of the 'see and treat' approach in women with a high-grade squamous intraepithelial lesion on Pap smears. J Obstet Gynaecol 2009;29:430-3 «PMID: 19603324»PubMed
  66. Kocken M, Uijterwaal MH, de Vries AL ym. High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis. Gynecol Oncol 2012;125:500-7 «PMID: 22266548»PubMed
  67. Kodiathodi S, Chattopadhyay S, Baldwin A ym. Management of borderline change in endocervical cells: a more dependable approach. Br J Cancer 2014;111:851-7 «PMID: 24967874»PubMed
  68. Kolstad P, Klem V. Long-term followup of 1121 cases of carcinoma in situ. Obstet Gynecol 1976;48:125-9 «PMID: 940642»PubMed
  69. Koshiol J, Lindsay L, Pimenta JM ym. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol 2008;168:123-37 «PMID: 18483125»PubMed
  70. Kyrgiou M, Koliopoulos G, Martin-Hirsch P ym. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006;367:489-98 «PMID: 16473126»PubMed
  71. Kyrgiou M, Mitra A, Arbyn M ym. Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2015;:CD008478 «PMID: 26417855»PubMed
  72. Kyrgiou M, Valasoulis G, Stasinou SM ym. Proportion of cervical excision for cervical intraepithelial neoplasia as a predictor of pregnancy outcomes. Int J Gynaecol Obstet 2015;128:141-7 «PMID: 25444615»PubMed
  73. Landy R, Castanon A, Hamilton W ym. Evaluating cytology for the detection of invasive cervical cancer. Cytopathology 2016;27:201-9 «PMID: 26126636»PubMed
  74. Leeson SC, Inglis TC, Salman WD. A study to determine the underlying reason for abnormal glandular cytology and the formulation of a management protocol. Cytopathology 1997;8:20-6 «PMID: 9068952»PubMed
  75. Lehtinen M, Paavonen J, Wheeler CM ym. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 2012;13:89-99 «PMID: 22075171»PubMed
  76. Leinonen M, Nieminen P, Kotaniemi-Talonen L ym. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst 2009;101:1612-23 «PMID: 19903804»PubMed
  77. Leinonen MK, Nieminen P, Lönnberg S ym. Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland. BMJ 2012;345:e7789 «PMID: 23197596»PubMed
  78. Leufflen L, Baermann P Jr, Rauch P ym. Treatment of vulvar intraepithelial neoplasia with CO(2) laser vaporization and excision surgery. J Low Genit Tract Dis 2013;17:446-51 «PMID: 23609594»PubMed
  79. Luff RD. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop. The Bethesda System Editorial Committee. Hum Pathol 1992;23:719-21 «PMID: 1612572»PubMed
  80. Lynge E. Cohort studies in evaluation of cervical cancer screening. Kirjassa: Evaluation and monitoring of screening programmes. Sankila R, Démaret E, Hakama M, Lynge E, Schouten LJ, Parkin DM for the European Network of Cancer Registries (toim.). European Commission, Europe Against Cancer Programme, Brussels - Luxembourg 2000:119-31
  81. Lönnberg S, Anttila A, Luostarinen T ym. Age-specific effectiveness of the Finnish cervical cancer screening programme. Cancer Epidemiol Biomarkers Prev 2012;21:1354-61 «PMID: 22665576»PubMed
  82. Lönnberg S, Nieminen P, Luostarinen T ym. Mortality audit of the Finnish cervical cancer screening program. Int J Cancer 2013;132:2134-40 «PMID: 22987437»PubMed
  83. Massad LS, Einstein MH, Huh WK ym. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2013;17:S1-S27 «PMID: 23519301»PubMed
  84. Massad LS. Outcomes after diagnosis of vaginal intraepithelial neoplasia. J Low Genit Tract Dis 2008;12:16-9 «PMID: 18162807»PubMed
  85. Mathers ME, Johnson SJ, Wadehra V. How predictive is a cervical smear suggesting glandular neoplasia? Cytopathology 2002;13:83-91 «PMID: 11952746»PubMed
  86. McAllum B, Sykes PH, Sadler L ym. Is the treatment of CIN 2 always necessary in women under 25 years old? Am J Obstet Gynecol 2011;205:478.e1-7 «PMID: 21872201»PubMed
  87. McCredie MR, Sharples KJ, Paul C ym. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9:425-34 «PMID: 18407790»PubMed
  88. McNally OM, Mulvany NJ, Pagano R ym. VIN 3: a clinicopathologic review. Int J Gynecol Cancer 2002;12:490-5 «PMID: 12366668»PubMed
  89. Meirovitz M, Gatt D, Dreiher J ym. Uterine cervix conization based on Pap smear results: the "see and treat" approach. Isr Med Assoc J 2014;16:303-6 «PMID: 24979836»PubMed
  90. Melnikow J, Nuovo J, Willan AR ym. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998;92:727-35 «PMID: 9764690»PubMed
  91. Milne DS, Wadehra V, Mennim D ym. A prospective follow up study of women with colposcopically unconfirmed positive cervical smears. Br J Obstet Gynaecol 1999;106:38-41 «PMID: 10426257»PubMed
  92. Misra JS, Singh U. Results of longterm hospital based cytological screening in asymptomatic women. Diagn Cytopathol 2006;34:184-7 «PMID: 16470854»PubMed
  93. Mitchell MF, Schottenfeld D, Tortolero-Luna G ym. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998;91:626-31 «PMID: 9540955»PubMed
  94. Moscicki AB, Hills N, Shiboski S ym. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001;285:2995-3002 «PMID: 11410098»PubMed
  95. Moscicki AB, Ma Y, Wibbelsman C ym. Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol 2010;116:1373-80 «PMID: 21099605»PubMed
  96. Moscicki AB, Shiboski S, Hills NK ym. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 2004;364:1678-83 «PMID: 15530628»PubMed
  97. Mukhopadhyay S, Ray S, Dhar S ym. Evaluation of the category high-grade squamous intraepithelial lesion in The Bethesda System for reporting cervical cytology. J Cytol 2013;30:33-5 «PMID: 23661938»PubMed
  98. Munk AC, Gudlaugsson E, Malpica A ym. Consistent condom use increases the regression rate of cervical intraepithelial neoplasia 2-3. PLoS One 2012;7:e45114 «PMID: 23028792»PubMed
  99. Nanda K, McCrory DC, Myers ER ym. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000;132:810-9 «PMID: 10819705»PubMed
  100. Nash JD, Burke TW, Hoskins WJ. Biologic course of cervical human papillomavirus infection. Obstet Gynecol 1987;69:160-2 «PMID: 3027635»PubMed
  101. Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986;67:665-9 «PMID: 3960438»PubMed
  102. Naucler P, Ryd W, Törnberg S ym. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007;357:1589-97 «PMID: 17942872»PubMed
  103. Nieminen P, Kallio M, Anttila A ym. Organised vs. spontaneous Pap-smear screening for cervical cancer: A case-control study. Int J Cancer 1999;83:55-8 «PMID: 10449608»PubMed
  104. Noehr B, Jensen A, Frederiksen K ym. Depth of cervical cone removed by loop electrosurgical excision procedure and subsequent risk of spontaneous preterm delivery. Obstet Gynecol 2009;114:1232-8 «PMID: 19935024»PubMed
  105. Noehr B, Jensen A, Frederiksen K ym. Loop electrosurgical excision of the cervix and subsequent risk for spontaneous preterm delivery: a population-based study of singleton deliveries during a 9-year period. Am J Obstet Gynecol 2009;201:33.e1-6 «PMID: 19345930»PubMed
  106. Numnum TM, Kirby TO, Leath CA 3rd ym. A prospective evaluation of "see and treat" in women with HSIL Pap smear results: is this an appropriate strategy? J Low Genit Tract Dis 2005;9:2-6 «PMID: 15870514»PubMed
  107. Nygård M, Saah A, Munk C ym. Evaluation of the Long-Term Anti-Human Papillomavirus 6 (HPV6), 11, 16, and 18 Immune Responses Generated by the Quadrivalent HPV Vaccine. Clin Vaccine Immunol 2015;22:943-8 «PMID: 26084514»PubMed
  108. Nøhr B, Tabor A, Frederiksen K ym. Loop electrosurgical excision of the cervix and the subsequent risk of preterm delivery. Acta Obstet Gynecol Scand 2007;86:596-603 «PMID: 17464590»PubMed
  109. Ostör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12:186-92 «PMID: 8463044»PubMed
  110. Owens GL, Kitchener HC. Premalignant disease in the genital tract in pregnancy. Best Pract Res Clin Obstet Gynaecol 2016;33:33-43 «PMID: 26597347»PubMed
  111. Palmer JE, Ravenscroft S, Ellis K ym. Does LLETZ excision margin status predict residual disease in women who have undergone post-treatment cervical cytology and high-risk human papillomavirus testing? Cytopathology 2016;27:210-7 «PMID: 26415635»PubMed
  112. Paraskevaidis E, Koliopoulos G, Kalantaridou S ym. Management and evolution of cervical intraepithelial neoplasia during pregnancy and postpartum. Eur J Obstet Gynecol Reprod Biol 2002;104:67-9 «PMID: 12128266»PubMed
  113. Paraskevaidis E, Lolis ED, Koliopoulos G ym. Cervical intraepithelial neoplasia outcomes after large loop excision with clear margins. Obstet Gynecol 2000;95:828-31 «PMID: 10831975»PubMed
  114. Penna C, Fallani MG, Maggiorelli M ym. High-grade cervical intraepithelial neoplasia (CIN) in pregnancy: clinicotherapeutic management. Tumori 1998;84:567-70 «PMID: 9862518»PubMed
  115. Petrilli ES, Townsend DE, Morrow CP ym. Vaginal intraepithelial neoplasia: Biologic aspects and treatment with topical 5-fluorouracil and the carbon dioxide laser. Am J Obstet Gynecol 1980;138:321-8 «PMID: 6774615»PubMed
  116. Pretorius RG, Belinson JL, Peterson P ym. Which Colposcopies Should Include Endocervical Curettage? J Low Genit Tract Dis 2015;19:278-81 «PMID: 26083335»PubMed
  117. Pretorius RG, Belinson JL, Zhang WH ym. The colposcopic impression. Is it influenced by the colposcopist's knowledge of the findings on the referral Papanicolaou smear? J Reprod Med 2001;46:724-8 «PMID: 11547646»PubMed
  118. Recommendations on cancer screening in the European union. Advisory Committee on Cancer Prevention. Eur J Cancer 2000;36:1473-8 «PMID: 10930794»PubMed
  119. Richardson H, Kelsall G, Tellier P ym. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003;12:485-90 «PMID: 12814991»PubMed
  120. Ronco G, Arbyn M, Meijer CJ, Snijders PJ, Cuzick J. Screening for cervical cancer with primary testing for human papillomavirus. S1. Kirjassa: European guidelines for quality assurance in cervical cancer screening. Second edition, Supplements. Anttila A, Arbyn M, De Vuyst H (toim.) Office for Official Publications of the European Union, Luxembourg 2015:1-68
  121. Ronco G, Dillner J, Elfström KM ym. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 2014;383:524-32 «PMID: 24192252»PubMed
  122. Ronco G, Giorgi-Rossi P, Carozzi F ym. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010;11:249-57 «PMID: 20089449»PubMed
  123. Rosenblatt KA, Osterbur EF, Douglas JA. Case-control study of cervical cancer and gynecologic screening: A SEER-Medicare analysis. Gynecol Oncol 2016;142:395-400 «PMID: 27388696»PubMed
  124. Rosenthal AN, Panoskaltsis T, Smith T ym. The frequency of significant pathology in women attending a general gynaecological service for postcoital bleeding. BJOG 2001;108:103-6 «PMID: 11212982»PubMed
  125. Roura E, Castellsagué X, Pawlita M ym. Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. Int J Cancer 2014;135:453-66 «PMID: 24338632»PubMed
  126. Rustagi AS, Kamineni A, Weinmann S ym. Cervical screening and cervical cancer death among older women: a population-based, case-control study. Am J Epidemiol 2014;179:1107-14 «PMID: 24685531»PubMed
  127. Ryu A, Nam K, Kwak J ym. Early human papillomavirus testing predicts residual/recurrent disease after LEEP. J Gynecol Oncol 2012;23:217-25 «PMID: 23094124»PubMed
  128. Sadan O, Yarden H, Schejter E ym. Treatment of high-grade squamous intraepithelial lesions: a "see and treat" versus a three-step approach. Eur J Obstet Gynecol Reprod Biol 2007;131:73-5 «PMID: 16516371»PubMed
  129. Salani R, Puri I, Bristow RE. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status. Am J Obstet Gynecol 2009;200:182.e1-5 «PMID: 19019325»PubMed
  130. Sanner K, Wikström I, Strand A ym. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer 2009;101:871-4 «PMID: 19654577»PubMed
  131. Sasieni P, Castanon A, Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ 2009;339:b2968 «PMID: 19638651»PubMed
  132. Schlecht NF, Kulaga S, Robitaille J ym. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001;286:3106-14 «PMID: 11754676»PubMed
  133. Schlecht NF, Platt RW, Duarte-Franco E ym. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst 2003;95:1336-43 «PMID: 12953088»PubMed
  134. Schnatz PF, Guile M, O'Sullivan DM ym. Clinical significance of atypical glandular cells on cervical cytology. Obstet Gynecol 2006;107:701-8 «PMID: 16507944»PubMed
  135. Screening for cancer of the uterine cervix. From the IARC Working Group on Cervical Cancer Screening and the UICC Project Group on the Evaluation of Screening Programmes for Cancer. IARC Sci Publ 1986;:1-315 «PMID: 3570396»PubMed
  136. Shafi MI, Luesley DM, Jordan JA ym. Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. Br J Obstet Gynaecol 1997;104:590-4 «PMID: 9166203»PubMed
  137. Shapley M, Jordan J, Croft PR. A systematic review of postcoital bleeding and risk of cervical cancer. Br J Gen Pract 2006;56:453-60 «PMID: 16762128»PubMed
  138. Solomon D, Davey D, Kurman R ym. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9 «PMID: 11966386»PubMed
  139. Solomon D, Stoler M, Jeronimo J ym. Diagnostic utility of endocervical curettage in women undergoing colposcopy for equivocal or low-grade cytologic abnormalities. Obstet Gynecol 2007;110:288-95 «PMID: 17666602»PubMed
  140. Soost HJ, Lange HJ, Lehmacher W ym. The validation of cervical cytology. Sensitivity, specificity and predictive values. Acta Cytol 1991;35:8-14 «PMID: 1994641»PubMed
  141. Stoler MH, Schiffman M, Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001;285:1500-5 «PMID: 11255427»PubMed
  142. Stonehocker J. Cervical cancer screening in pregnancy. Obstet Gynecol Clin North Am 2013;40:269-82 «PMID: 23732031»PubMed
  143. Syrjänen K, Kataja V, Yliskoski M ym. Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. Obstet Gynecol 1992;79:675-82 «PMID: 1314359»PubMed
  144. Söderlund-Strand A, Kjellberg L, Dillner J. Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia. J Med Virol 2014;86:634-41
  145. Tarney CM, Han J. Postcoital bleeding: a review on etiology, diagnosis, and management. Obstet Gynecol Int 2014;2014:192087 «PMID: 25045355»PubMed
  146. Teale GR, Moffitt DD, Mann CH ym. Management guidelines for women with normal colposcopy after low grade cervical abnormalities: population study. BMJ 2000;320:1693-6 «PMID: 10864542»PubMed
  147. Terlou A, van Seters M, Ewing PC ym. Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial. Gynecol Oncol 2011;121:157-62 «PMID: 21239049»PubMed
  148. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop. JAMA 1989;262:931-4 «PMID: 2754794»PubMed
  149. Thorsteinsson K, Ladelund S, Jensen-Fangel S ym. Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general population. HIV Med 2016;17:7-17 «PMID: 26058995»PubMed
  150. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ 2009;339:b2548 «PMID: 19638647»PubMed
  151. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ 2009;339:b2546 «PMID: 19638646»PubMed
  152. Wallbillich JJ, Rhodes HE, Milbourne AM ym. Vulvar intraepithelial neoplasia (VIN 2/3): comparing clinical outcomes and evaluating risk factors for recurrence. Gynecol Oncol 2012;127:312-5 «PMID: 22867736»PubMed
  153. van Seters M, van Beurden M, de Craen AJ. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol 2005;97:645-51 «PMID: 15863172»PubMed
  154. van Seters M, van Beurden M, ten Kate FJ ym. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med 2008;358:1465-73 «PMID: 18385498»PubMed
  155. Verdoodt F, Jentschke M, Hillemanns P ym. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer 2015;51:2375-85 «PMID: 26296294»PubMed
  156. Verdoodt F, Jiang X, Williams M ym. High-risk HPV testing in the management of atypical glandular cells: A systematic review and meta-analysis. Int J Cancer 2016;138:303-10 «PMID: 25583258»PubMed
  157. Vicus D, Sutradhar R, Lu Y ym. The association between cervical cancer screening and mortality from cervical cancer: a population based case-control study. Gynecol Oncol 2014;133:167-71 «PMID: 24589414»PubMed
  158. Viikki M, Pukkala E, Hakama M. Risk of cervical cancer after a negative Pap smear. J Med Screen 1999;6:103-7 «PMID: 10444730»PubMed
  159. Viikki M, Pukkala E, Nieminen P ym. Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol 2000;39:71-5 «PMID: 10752657»PubMed
  160. Virtanen A, Anttila A, Luostarinen T ym. Improving cervical cancer screening attendance in Finland. Int J Cancer 2015;136:E677-84 «PMID: 25178683»PubMed
  161. Virtanen A, Nieminen P, Luostarinen T ym. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol Biomarkers Prev 2011;20:1960-9 «PMID: 21752985»PubMed
  162. Wright TC Jr, Massad LS, Dunton CJ ym. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis 2007;11:223-39 «PMID: 17917567»PubMed
  163. Wu YM, Wang T, He Y ym. Clinical management of cervical intraepithelial neoplasia in pregnant and postpartum women. Arch Gynecol Obstet 2014;289:1071-7 «PMID: 24196304»PubMed
  164. Yang KY. Abnormal pap smear and cervical cancer in pregnancy. Clin Obstet Gynecol 2012;55:838-48 «PMID: 22828115»PubMed
  165. Yost NP, Santoso JT, McIntire DD ym. Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and III lesions. Obstet Gynecol 1999;93:359-62 «PMID: 10074979»PubMed
  166. Zappa M, Visioli CB, Ciatto S ym. Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence. Br J Cancer 2004;90:1784-6 «PMID: 15150597»PubMed
  167. Zeligs KP, Byrd K, Tarney CM ym. A clinicopathologic study of vaginal intraepithelial neoplasia. Obstet Gynecol 2013;122:1223-30 «PMID: 24201676»PubMed
  168. Zhao C, Florea A, Onisko A ym. Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods. Gynecol Oncol 2009;114:383-9 «PMID: 19501894»PubMed
  169. Zorzi M, Del Mistro A, Farruggio A ym. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study. BJOG 2013;120:1260-7; discussion 1267-8 «PMID: 23786222»PubMed
Artikkelin tunnus: nix02950 (050.049)
© 2023 Suomalainen Lääkäriseura Duodecim

Käypä hoito -suositus

Anna palautetta
Linkkien värikoodit